Udho Thadani to Exercise Test
This is a "connection" page, showing publications Udho Thadani has written about Exercise Test.
Connection Strength
0.700
-
Lack of arrhythmogenicity with ST-segment elevation during high-dose of dobutamine atropine stress in patients with documented or suspected coronary artery disease. Am J Cardiol. 1997 Aug 01; 80(3):341-3.
Score: 0.132
-
Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Am Heart J. 2009 Oct; 158(4 Suppl):S72-7.
Score: 0.077
-
The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. J Am Coll Cardiol. 2002 Dec 04; 40(11):2006-12.
Score: 0.048
-
Are the clinical and hemodynamic events during exercise stress testing in invasive studies in patients with angina pectoris reproducible? Circulation. 1980 Apr; 61(4):744-50.
Score: 0.040
-
Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris. Am J Cardiol. 1997 Apr 15; 79(8):1025-30.
Score: 0.032
-
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group. Circulation. 1994 Aug; 90(2):726-34.
Score: 0.027
-
Duration of effects of isradipine during twice daily therapy in angina pectoris. Cardiovasc Drugs Ther. 1994 Apr; 8(2):199-210.
Score: 0.026
-
Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris. Am J Cardiol. 1992 Aug 01; 70(3):286-92.
Score: 0.023
-
Amlodipine: a once-daily calcium antagonist in the treatment of angina pectoris--a parallel dose-response, placebo-controlled study. The Amlodipine Study Group. Am Heart J. 1989 Nov; 118(5 Pt 2):1135.
Score: 0.019
-
Mechanisms of myocardial ischemia induced by epinephrine: comparison with exercise-induced ischemia. Psychosom Med. 1988 Jul-Aug; 50(4):381-93.
Score: 0.018
-
Long-term bepridil monotherapy for angina pectoris. Am J Cardiol. 1988 Jun 01; 61(15):1210-3.
Score: 0.018
-
Amlodipine--a once-daily calcium antagonist in the treatment of angina pectoris: a parallel dose-response placebo-controlled study. J Cardiovasc Pharmacol. 1988; 12 Suppl 7:S114.
Score: 0.017
-
Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris. Am J Cardiol. 1987 Sep 01; 60(7):477-82.
Score: 0.017
-
Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy. Clin Pharmacol Ther. 1987 Jul; 42(1):58-65.
Score: 0.016
-
Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris. Am J Cardiol. 1987 Apr 01; 59(8):756-62.
Score: 0.016
-
Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance. Ann Intern Med. 1986 Oct; 105(4):485-92.
Score: 0.016
-
Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris. Am J Cardiol. 1985 Mar 15; 55(7):36C-42C.
Score: 0.014
-
Assessment of "optimal" beta blockade in treating patients with angina pectoris. Acta Med Scand Suppl. 1985; 694:178-87.
Score: 0.014
-
Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina. Eur Heart J. 2003 Dec; 24(24):2206-12.
Score: 0.013
-
Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris. Am J Cardiol. 2003 Feb 01; 91(3):274-9.
Score: 0.012
-
Hemodynamic effects of disopyramide at rest and during exercise in normal subjects. Cathet Cardiovasc Diagn. 1981; 7(1):27-34.
Score: 0.010
-
Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy. Circulation. 1980 Sep; 62(3):491-502.
Score: 0.010
-
Propranolol in angina pectoris: comparison of therapy given two and four times daily. Am J Cardiol. 1980 Jul; 46(1):117-23.
Score: 0.010
-
Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris. Am J Med. 1980 Feb; 68(2):243-50.
Score: 0.010
-
Effects of low and high glucose in a glucose-insulin-potassium infusion on hemodynamics and exercise tolerance in patients with angina pectoris. Circulation. 1980 Feb; 61(2):266-76.
Score: 0.010
-
Reproducibility of clinical and hemodynamic parameters during pacing stress testing in patients with angina pectoris. Circulation. 1979 Nov; 60(5):1036-44.
Score: 0.010
-
Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration. Am J Cardiol. 1979 Jul; 44(1):118-25.
Score: 0.009
-
Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris. N Engl J Med. 1979 Apr 05; 300(14):750-5.
Score: 0.009
-
Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy. Circulation. 1979 Mar; 59(3):571-9.
Score: 0.009
-
Effects of glucose-insulin-potassium infusion on the angina response during treadmill exercise. Cardiology. 1979; 64(6):333-49.
Score: 0.009
-
Hemodynamics at rest and during supine and sitting bicycle exercise in patients with coronary artery disease. Am J Cardiol. 1977 May 26; 39(6):776-83.
Score: 0.008